The role of androgen deprivation therapy in high-risk prostate cancer with Gleason score 8-10 and prostate-specific antigen ≤15 treated with permanent interstitial brachytherapy
L. Christine Fang, Gregory S. Merrick, Brian C. Murray, Kent E. Wallner, Wayne M. Butler, Robert L. GalbreathVolume:
8
Année:
2009
Langue:
english
DOI:
10.1016/j.brachy.2009.03.147
Fichier:
PDF, 46 KB
english, 2009